Abstract
A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.
Original language | English (US) |
---|---|
Pages (from-to) | 1725-1726 |
Number of pages | 2 |
Journal | Archives of Internal Medicine |
Volume | 138 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1978 |
Externally published | Yes |
ASJC Scopus subject areas
- Internal Medicine